Clinical Outcomes |
UV4V |
UV9V |
Cases Averted, No.b (%) |
CIN1 |
2 386 845 |
1 057 643 |
1 329 202 (56) |
CIN2/3 |
1 615 718 |
808 398 |
807 320 (50) |
VaIN1 |
46 928 |
33 590 |
13 338 (28) |
VaIN2/3 |
67 449 |
50 556 |
16 894 (25) |
Total cancers |
314 709 |
274 301 |
40 409 (13) |
Female cancers |
220 173 |
185 661 |
34 512 (16) |
Cervical |
106 963 |
82 500 |
24 463 (16) |
Other |
113 209 |
103 161 |
10 048 (9) |
Anal |
34 819 |
32 932 |
1887 (5) |
Vaginal |
14 311 |
12 873 |
1437 (10) |
Vulvar |
54 000 |
48 069 |
5931 (11) |
H&Nc |
10 080 |
9286 |
794 (8) |
Male cancers |
94 537 |
88 640 |
5897 (6) |
Anal |
27 280 |
26 104 |
1176 (4) |
H&Nc |
22 932 |
21 212 |
1720 (7) |
Penile |
44 325 |
41 323 |
3001 (7) |
Total deaths |
59 149 |
53 440 |
5708 (9) |
Female deaths |
38 346 |
33 862 |
4483 (11) |
Cervical |
22 821 |
19 568 |
3253 (14) |
Vaginal |
3433 |
3146 |
287 (8) |
Vulvar |
6742 |
6120 |
621 (9) |
Anal |
2505 |
2376 |
129 (5) |
H&Nc |
2845 |
2652 |
193 (7) |
Male deaths |
20 803 |
19 578 |
1225 (6) |
Penile |
11 133 |
10 478 |
654 (6) |
Anal |
2538 |
2438 |
100 (4) |
H&Nc |
7132 |
6662 |
470 (7) |